Valuation: Takeda Pharmaceutical Company Limited

Market Cap 10,202B 65.06B 58.1B 53.67B 48.64B 91B 6,176B 92.5B 646B 256B 3,236B 244B 239B P/E 2027 *
50.6x
P/E 2028 * 32.1x
Enterprise Value 14,109B 89.98B 80.35B 74.23B 67.27B 126B 8,542B 128B 893B 354B 4,475B 338B 330B EV / Sales 2027 *
3x
EV / Sales 2028 * 2.9x
Free-Float
99.18%
Yield 2027 *
3.2%
Yield 2028 * 3.26%
1 day+0.65%
1 week+2.67%
Current month+10.54%
1 month+7.05%
3 months+16.06%
6 months+19.85%
Current year+32.14%
1 week 6,200
Extreme 6200
6,500
1 month 5,606
Extreme 5606
6,500
Current year 4,710
Extreme 4710
6,500
1 year 4,102
Extreme 4102
6,500
3 years 3,852
Extreme 3852
6,500
5 years 2,993
Extreme 2993
6,500
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 31/12/2024
Director of Finance/CFO 48 31/03/2024
Chief Tech/Sci/R&D Officer 48 31/01/2022
Director TitleAgeSince
Director/Board Member 61 31/05/2015
Director/Board Member 73 31/12/2018
Director/Board Member 48 31/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Sell

Executive/Senior Manager

-34,535 0.0022%
02/09/26 Sell

Chief Technology Officer

-116,191 0.0073%
19/08/26 Sell

Chief Technology Officer

-19,651 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+2.67%+49.00%+46.67% 65.06B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.54%+2.22%+38.12%+68.47% 406.94B
Weighted average by Cap. -0.24%+2.66%+41.12%+81.56%

Financials

2027 *2028 *
Net sales 4,704B 30B 26.79B 24.75B 22.43B 41.96B 2,848B 42.66B 298B 118B 1,492B 113B 110B 4,796B 30.58B 27.31B 25.23B 22.87B 42.78B 2,903B 43.49B 304B 120B 1,521B 115B 112B
Net income 196B 1.25B 1.12B 1.03B 936M 1.75B 119B 1.78B 12.43B 4.92B 62.27B 4.7B 4.6B 323B 2.06B 1.84B 1.7B 1.54B 2.88B 196B 2.93B 20.45B 8.1B 102B 7.73B 7.57B
Net Debt 3,907B 24.92B 22.25B 20.56B 18.63B 34.85B 2,366B 35.43B 247B 97.94B 1,239B 93.52B 91.53B 3,705B 23.63B 21.1B 19.49B 17.66B 33.05B 2,243B 33.59B 235B 92.86B 1,175B 88.67B 86.78B
Projected Income Statement - Annual - Takeda Pharmaceutical Company Limited
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
23/10/26 JP¥6,389.00 +0.65% 4,435,900
22/10/26 JP¥6,348.00 +0.52% 4,775,400
21/10/26 JP¥6,315.00 +0.08% 5,079,500
20/10/26 JP¥6,310.00 +1.06% 3,771,000
19/10/26 JP¥6,244.00 +0.34% 3,572,600
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Takeda Pharmaceutical Company Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
6,389.00JPY
Average target price
6,684.56JPY
Spread / Average Target
+4.63%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Takeda Pharmaceutical Company Limited
  1. Stock Market
  2. Stocks
  3. 4502 Stock